Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06109415
PHASE4

Cohort 1 (TSA) of: A Multi-surgery Assessment of ZYNRELEF (HTX-011)

Sponsor: Heron Therapeutics

View on ClinicalTrials.gov

Summary

Cohort 1 (subjects undergoing total shoulder arthroplasty, TSA) of a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing different surgical procedures. See also the separate record for the master study protocol (NCT05109312).

Official title: A Phase 4, Randomized, Blinded, Active-Controlled Study of HTX-011 in Subjects Undergoing Different Surgical Procedures, Cohort 1: Total Shoulder Arthroplasty (TSA)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2021-10-20

Completion Date

2022-07-29

Last Updated

2026-10-27

Healthy Volunteers

No

Interventions

DRUG

HTX-011

HTX-011 (bupivacaine/meloxicam) extended-release solution for instillation use, supplied in commercially available ZYNRELEF kits

DRUG

Bupivacaine Hydrochloride

bupivacaine HCl (without epinephrine) 0.25%

DRUG

MMA regimen

acetaminophen 1 g q8h every 8 hours (q8h) and ibuprofen 400 mg q8h, alternating the 2 medications so that an analgesic was taken approximately every 4 hours (q4h)

DEVICE

ZYNRELEF kit components for administration

ZYNRELEF kits include sterile, individually packaged components for administration, including vented vial spikes, Luer lock syringes, custom Luer lock applicators, and syringe tip caps.

Locations (5)

Woodland International Research Group, LLC

Little Rock, Arkansas, United States

Center for Orthopaedic Reconstruction and Excellence

Jenks, Oklahoma, United States

First Surgical Hospital

Bellaire, Texas, United States

Legent Orthopedic Hospital

Carrollton, Texas, United States

JBR Clinical Research

Salt Lake City, Utah, United States